Summary
Following prolonged administration of tolbutamide the DNA- and protein content per islet was enhanced but the IRI content per islet was diminished. Glucose-induced (2.0,8.0 or 16.6 mM) and leucine-induced (12.5 or 25.0 mM) IRI release from isolated islets, as well as 14CO2-production from U-14C glucose, were decreased. Theophylline (5.0 mM) restored the glucose sensitivity of the islets towards normal. The results indicate that tolbutamide-induced islet cell hyperplasia does not entail islet hyperfunction, as previously thought. Decreased IRI release may partially be explained by a tolbutamide-induced alteration of the adenylate cyclase/phosphodiesterase system of the B-cell.
Article PDF
Similar content being viewed by others
References
Creutzfeldt, W.: Current views on the mode of action of hypoglycemic sulfonamides. Acta diabet. lat. 6 (suppl. 1), 201–215 (1969)
Reaven, G., Dray, J.: Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes. Diabetes 16, 487–492 (1967)
Boshell, B.R., Fox, O.J., Roddam, R.F., Hill, P.S.: The effect of sulfonylurea agents on insulin secretion and insulin reserve. In: Tolbutamide ... after ten years (ed. W.J.H. Butterfield, W. van Westering), p. 286–297. Amsterdam: Excerpta Med. Found. I.C.S. 149, 1967
Sheldon, J., Taylor, T.W., Anderson, J.: The effect of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes. Metabolism 15, 874–883 (1966)
Chu, P., Conway, M.J., Krouse, H.A., Goodner, Ch.J.: The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann. intern. Med. 68, 757–769 (1968)
Duckworth, W.C., Solomon, S.S., Kitabchi, A.E.: Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. J. clin. Endocr. 35, 585–591 (1972)
Johansen, K., Ørskov, H.: The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Acta Endocrinol. 71, 709–715 (1972)
Kracht, J., v. Holt, C., v. Holt, L.: Morphologische Befunde zur Wirkungsweise oraler Antidiabetika. Endokrinologie 34, 129–146 (1957)
Gepts, W., Christophe, J., Bellens, R.: Étude expérimentale du BZ 55 sur le rat normal ou alloxanisé. Modifications morphologiques et en particulier pancréatiques. Ann. Endocr. (Paris) 17, 278 (1956)
Ashworth, M.A., Haist, R.E.: Some effects of BZ 55 (carbutamide) on growth of islets of Langerhans. Canad. med. Ass. J. 74, 459–464 (1956)
Gepts, W.: Étude histologique de l'effet des sulfamides hypoglycémiants sur les ilôts de Langerhans du rat. Ann. Endocr. (Paris) 18, 204–213 (1957)
Volk, B.W., Lazarus, S.S.: B-cell hyperfunction after long-term sulfonylurea treatment. Arch. Path. 78, 114–125 (1964)
Loubatières, A., Mariani, M.M., Alric, R., Houareau, M.M.: Étude chez le rat du dévelopement des ilôts de Langerhans sous l'effet de l'administration chronique, séparée ou combinée, de tolbutamide et de diazoxide. C. R. Soc. Biol. (Paris) 162, 191–196 (1968)
Loubatières, A., Ribes, G., Mariani, M.M., Alric, R.: Pharmacological comparison between tolbutamide and two second generation hypoglycemie sulfonylureas (glibenclamide and glisoxepide). Acta diabet. lat 10, 261–282 (1973)
Creutzfeldt, W., Geginat, G.: Glukosetoleranz and Inselregeneration bei teilpankreatektomierten Ratten unter ACTH und langfristiger Behandlung mit N′-(4-Methyl-benzolsulfonyl)-N′-butylharnstoff. Arzneimittel-Forsch. 8, 464–469 (1958)
Dunbar, J.C., Foa, P.P.: An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals. Diabetologia 10, 27–35 (1974)
Sodoyez, J.C., Sodoyez-Goffaux, F., Dunbar, J.C., Foa, P.P.: Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea. Diabetes 19, 603–609 (1970)
Sodoyez, J.C., Sodoyez-Goffaux, F.: Effect of daily injection of tolbutamide into pregnant rats on the pancreatic insulin content of their offspring. Metabolism 22, 1389–1393 (1973)
Bates, R.W., Garrison, M.M.: Daily changes in concentration of pancreatic and serum insulin and of blood glucose during 5 days of treatment of rats with growth hormone, ACTH, cortisol, dexamethasone, and tolbutamide alone and in combinations. Metabolism 23, 947–965 (1974)
Schauder, P., Frerichs, H.: Cytochalasin B.: Inhibition of glucose-induced insulin release from isolated rat pancreatic islets. Diabetologia 10, 85–87 (1974)
Lacy, P.E., Kostianovsky, M.: Method for the isolation of intact islets of Langerhans from rat pancreas. Diabetes 16, 35–39 (1967)
Gerner, L., L'Age-Stehr, J., Tjioe, T.O., Wacker, A.: Zur Isolierung Langerhansscher Inseln aus Rattenpankreas. Hoppe-Seylers Z. physiol. Chem. 351, 309–312 (1970)
Melani, F., Ditschuneit, H., Bartelt, K.M., Friedrich, H., Pfeiffer, E.F.: Über die radioimmunologische Bestimmung von Insulin im Blut. Klin. Wschr. 43, 1000–1007 (1965)
Green, I.C., Taylor, K.W.: Effect of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J. Endocr. 54, 317–352 (1972)
Morris, G.E., Korner, A.: The effect of glucose on insulin biosynthesis by isolated islets of Langerhans of the rat. Biochim. biophys. Acta (Amst.) 208, 404–413 (1970)
Tjioe, T.O., Wacker, A.: Einfluß oraler Antidiabetika auf die Proinsulinbiosynthese bei der Ratte. Arzneimittel-Forsch. 22, 1890–1892 (1972)
Schatz, H., Maier, V., Hintz, M., Nierle, C., Pfeiffer, E.F.: The effect of tolbutamide and glibenclamide on the incorporation of 3H leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets. FEBS Letters 26, 237–240 (1972)
Hellman, B., Idahl, L.A., Danielsson, A.: Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemie sulfonylurea. Diabetes 18, 509–516 (1969)
Idahl, L.A.: Glucose-6-phosphate content in mammalian pancreatic β-cells. Effects of various stimulators and inhibitors of insulin release. Hormones 2, 371–377 (1971)
Stork, H., Schmidt, F.H., Hellerström, C., Westman, S.: Respiration of the β-cells in the presence of sulfonylureas. In: The structure and metabolism of pancreatic islets (ed. S. Falkmer, B. Hellman, I.B. Täljedal), pp. 331–336. Oxford and New York: Pergamon Press 1970
Westman, S., Hellerström, C.: Metabolism of the pancreatic beta-cells of mice in the presence of hypoglycémic sulfonylureas. Postgrad, med. J., Suppl. 46, 28–31 (1970)
Georg, R.H., Sussman, K.E., Leitner, J.W., Kirsch, W.M.: Inhibition of glucose and tolbutamide-induced insulin release by iodoacetate and antimycin A. Endocrinology 89, 169–176 (1971)
Krzanowsky, J.J., Jr., Fertel, R., Matschinsky, F.M.: Energy metabolism in pancreatic islets of rats. Studies with tolbutamide and hypoxia. Diabetes 20, 598–606 (1971)
Malaisse, W.J., Malaisse-Lagae, F., Mayhew, D.: A possible role for the adenylcyclase system in insulin secretion. J. clin. Invest. 46, 1724–1734 (1967)
Lacy, P.E., Young, D.A., Fink, C.J.: Studies on insulin secretion in vitro from isolated islets of the rat pancreas. Endocrinology 83, 1155–1161 (1968)
Coll-Garcia, E., Gill, J.R.: Insulin release by isolated pancreatic islets of the mouse incubated in vitro. Diabetologia 5, 61–68 (1969)
Sams, D.J., Montague, W.: The role of adenosine 3′:5′-cyclic monophosphate in the regulation of insulin release. Biochem. J. 129, 945–952 (1972)
Kuo, W.N., Hodgins, D.S., Kuo, F.J.: Adenylate cyclase in islets of Langerhans. J. biol. Chem. 248, 2705–2711 (1973)
Bowen, V., Lazarus, N.R.: Glucose-mediated insulin release: 3′,5′-phosphodiesterase. Diabetes 22, 738–743 (1973)
Montague, W., Howell, S.L.: The mode of action of adenosine 3′:5′ cyclic monophosphate in mammalian islets of Langerhans. Biochem. J. 134, 321–327 (1973)
Goldfine, I.D., Perlman, R., Roth, J.: Inhibition of 3′, 5′-AMP phosphodiesterase in islet cells and other tissues by tolbutamide Nature 234, 295–297 (1971)
Bowen, V., Lazarus, N.R.: Insulin release from the perfused rat pancreas. Mode of action of tolbutamide. Biochem. J. 142, 385–389 (1974)
Loreti, L., Sugase, T., Foa, P.P.: Diural variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide Hormone Res. 5, 278–292 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schauder, P., Frerichs, H. Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets. Diabetologia 11, 301–305 (1975). https://doi.org/10.1007/BF00422395
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422395